[1] Mohamed, Shengir S , Krishnamurthy P , et al. Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome[J]. World Journal of Gastroenterology, 2020, 26(44):142-156.
[2] Gao Z, Ma X, Liu J, et al. Troxerutin protects against DHT-induced polycystic ovary syndrome in rats[J]. Journal of Ovarian Research, 2020, 13(1):106.
[3] ML Sánchez-Ferrer, Adoamnei E , MT Prieto-Sánchez, et al. Health-related quality of life in women with polycystic ovary syndrome attending to a tertiary hospital in Southeastern Spain: a case-control study[J]. Health and quality of life outcomes, 2020, 18(1):232.
[4] Ashraf S , Rasool S , Nabi M , et al. Impact of rs2414096 polymorphism of CYP19 gene on susceptibility of polycystic ovary syndrome and hyperandrogenism in Kashmiri women[J]. Scientific Reports, 2021, 11(1):12942.
[5] Yang Z, Zhou W, Zhou C, et al. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome[J]. The Journal of Steroid Biochemistry and Molecular Biology, 2020, 206:105806.
[6] Ignatov A, Ortmann O. Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen[J]. Cancers, 2020, 12(7):1766.
[7] Messinis I E , Messini C I , Dafopoulos K . Obesity in polycystic ovary syndrome and infertility[J]. Obesity and Gynecology (Second Edition), 2020:23-34.
[8] Diamond M P , Legro R S , Coutifaris C , et al. Sexual Function in Infertile Women with Polycystic Ovary Syndrome and Unexplained Infertility[J]. American Journal of Obstetrics and Gynecology, 2017:S000293781730563X.
[9] Akpata C B , Uadia P O , Okonofua F E . Prevalence of Polycystic Ovary Syndrome in Nigerian Women with Infertility: A Prospective Study of the Three Assessment Criteria[J]. Open Journal of Obstetrics and Gynecology, 2018, 8(12):1109-1120.
[10] Morgante G , Massaro M G , Di Sabatino A , et al. Therapeutic approach for metabolic disorders and infertility in women with PCOS[J]. Gynecological Endocrinology, 2017:1-6.
[11] The Cochrane Collaboration.Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [EB/OL]. [2011-03] www.cochrane.org /training /cochrane-handbook.
[12] Cai Dandan. Effect of combined drugs on infertility caused by polycystic ovary syndrome[J]. Chinese Journal of Urban and Rural Industrial Hygiene, 2019, 34(2):85-86.
[13] Wang Haiyan, Pan Jianshu. Clinical study on 21 cases of infertility with kidney Yang deficiency induced by polycystic ovary syndrome treated with integrated traditional Chinese and Western Medicine[J]. Jiangsu Journal of Traditional Chinese Medicine, 2016, 48(12):30-32.
[14] Yu Xianrong, Hong Xiaoqin. Effects of compound Xuanju capsules combined with progesterone and clomiphene on sex hormone level and pregnancy in patients with PCOS infertility[J]. Medical Innovation of China, 2021, 18(19):83-86.
[15] Sun Jinlong, Lian Fang, Sun Zhengao. Clinical observation of compound Xuanju capsules combined with letrozole in the treatment of 45 cases of infertility with polycystic ovary syndrome of kidney Yang deficiency[C]. Proceedings of the 9th National Symposium on Gynecology of traditional Chinese medicine, 2009:579-682.
[16] Zhang Juanjuan, Zhang Chunlian, Wang Chaoyun, et al. Progesterone combined with compound Xuanju capsules in the treatment of infertility caused by polycystic ovary syndrome[J]. The Chinese Journal of Human Sexuality, 2017, 26(8):121-123.
[17] Huang Xiaohong. Clinical observation of compound Xuanju capsules combined with clomiphene in the treatment of infertility with polycystic ovary syndrome[J]. Maternal and child health care of China, 2012, 27(33):5426-5428.
[18] Li Gang. Clinical study of compound Xuanju capsules combined with triptorelin in the treatment of infertility with polycystic ovary syndrome[J]. Chinese Journal of Modern Drug Application, 2020, 14(4):11-13.
[19] Hu Yunfang, Huang Yi, Li Liuming. Effect of compound Xuanju capsule, clomiphene and estradiol valerate on polycystic ovary syndrome complicated with infertility (kidney Yang deficiency type)[J]. Maternal and child health care of China, 2017, 32(12):2705-2708.
[20] Hao Lina, Xia Tinge. Clinical efficacy of compound Xuanju capsules combined with letrozole in the treatment of infertility with polycystic ovary syndrome[J]. Clinical Medical Research and Practice, 2018, 3(32):144-145.
[21] Chen Zhifang, Shen Jufeng, Shi Genmei. Progesterone combined with compound Xuanju capsules in the treatment of infertility with polycystic ovary syndrome and its effect on ovarian function[J]. Chinese Journal of Family Planning, 2019, 27(2):72-75.
[22] Yan Li. Effect of compound Xuanju capsules combined with tamoxifen on sex hormone level and pregnancy rate in infertile patients with polycystic ovary syndrome[J]. China's Naturopathy, 2019, 27(4):77-79.
[23] Ge Bingbing. Clinical effect of compound Xuanju capsules combined with clomiphene and progesterone Capsule on infertility patients with polycystic ovary syndrome[J]. Henan Medical Research, 2021, 30(8):1499-1501.
[24] Zhou Qingmin. Effect of compound Xuanju capsules combined with tamoxifen on infertility patients with polycystic ovary syndrome[J]. Henan Medical Research, 2020, 29(4):688-689.
[25] Li Yingying. Effect of compound Xuanju capsules combined with ethinylestradiol and cyproterone tablets on infertility patients with polycystic ovary syndrome[J]. Medical Journal of Chinese People's Health, 2021, 33(13):67-69.